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Schizophrenia is a severe psychiatric disorder with a lifetime risk of about 1% world-wide. Most 89 large schizophrenia genetic studies have studied people of primarily European ancestry, 90 potentially missing important biological insights. Here we present a study of East Asian 91 participants (22,778 schizophrenia cases and 35,362 controls), identifying 21 genome-wide 92 significant schizophrenia associations in 19 genetic loci. Over the genome, the common genetic 93 variants that confer risk for schizophrenia have highly similar effects in those of East Asian and 94
European ancestry (r g =0.98), indicating for the first time that the genetic basis of schizophrenia 95 and its biology are broadly shared across these world populations. A fixed-effect meta-analysis 96 including individuals from East Asian and European ancestries revealed 208 genome-wide 97 significant schizophrenia associations in 176 genetic loci (53 novel). Trans-ancestry fine-98 mapping more precisely isolated schizophrenia causal alleles in 70% of these loci. Despite 99 consistent genetic effects across populations, polygenic risk models trained in one population 100 have reduced performance in the other, highlighting the importance of including all major 101 ancestral groups with sufficient sample size to ensure the findings have maximum relevance for 102 all populations. 103
Schizophrenia is an often disabling psychiatric disorder which occurs worldwide with a lifetime 104 risk of about 1% 1 . It is well-established that genetic factors contribute to susceptibility of 105 schizophrenia. Recently, 145 genetic loci have been associated with schizophrenia in samples 106 of primarily European ancestry 2,3 (EUR) but this still represents the tip of the iceberg with 107 respect to common variant liability to the disorder: the highly polygenic nature of common 108 variation underlying this disorder predicts that there are hundreds more loci to be discovered 4 . 109
Most genetic studies of schizophrenia have been in EUR samples with relatively few 110 studies in other populations 5-8 . This is a significant deficiency for multiple reasons, particularly 111 as it greatly limits the discovery of biological clues about schizophrenia. For some causal 112 variants, ancestry-related heterogeneity yields varying allele frequency and linkage 113 disequilibrium (LD) patterns such that associations that can be detected in one population may 114 not be readily detected in others. Examples include a nonsense variant in TBC1D4 which 115 confers muscle insulin resistance and increases risk for type 2 diabetes that is common in 116 Greenland but is rare or absent in other populations 9 , several Asian-specific coding variants 117 which influence blood lipids 10 , a variant highly protective against alcoholism that is common in 118 Asian populations but very uncommon elsewhere 11 , and two loci associated with major 119 depression 12 that are more common in the Chinese populations than EUR 12,13 (rs12415800: 45% 120 versus 2%, and rs35936514: 28% versus 6%). 121
Even if alleles have similar frequencies across populations, the effects of alleles on risk 122 might be specific to certain populations if there are prominent but local contributions of clinical 123 heterogeneity, gene-environment (GxE) or gene-gene (GxG) interactions. In addition, there 124 have been debates about differences in prevalence, symptomatology, etiology, outcome, and 125 course of illness across geographical regions [14] [15] [16] [17] [18] [19] . Understanding the genetic architecture of 126 schizophrenia across populations provides insights in whether any differences represent 127 etiologic heterogeneity on the illness. 128 from Singapore, Japan, Indonesia, Korea, Hong Kong, Taiwan, and mainland China (Extended 138 Data Table 1 ). Individual-level genotypes were available from 16 samples (Extended Data Table  139 1a), on which we performed quality control, imputation and association tests (Methods and 140 Supplementary Table 1 ). Two samples (TAI-1 and TAI-2) were trio-based and pseudo-controls 141 were used. Four samples made available summary statistics for 22K-31K selected variants 142 (Methods) which had been analyzed in published studies 7, 8 . 143
We used a two-stage study design (Extended Data Fig. 1a and Supplementary Table 2 ), an additional 14 associations over the most 154 recent schizophrenia genetic study of Chinese ancestry 8 . Most associations were characterized 155 by marked differences in allele frequencies between the EAS and EUR samples: for 15 of 21 156 loci, the index variants had a higher minor allele frequencies (MAF) in EAS than EUR. The 157 higher allele frequency potentially confers better power to detect associations in EAS. For 158 example, we identified a locus ( Fig. 1b ) with the top association (rs374528934) having strong 159 evidence in EAS (P = 5 x 10 -11 ) but not in EUR using the Stage 1 samples. rs374528934 has 160 MAF of 45% in EAS but only 0.7% in EUR. No other variant in this locus is significantly 161 associated with schizophrenia in EUR. This locus contains CACNA2D2 (the calcium channel 162 α 2δ-2 subunit) associated with childhood epilepsy 22,23 , and to which the anticonvulsant 163 medication gabapentin binds, suggesting a path for further therapeutic investigation 23 . This 164 finding also adds new evidence to the calcium signaling pathway suggested to be implicated in 165 psychiatric disorders 24, 25 . The absence of the MHC association is evaluated in Discussion. 166 167
Genetic effects are consistent across populations 168
While it is assumed that biological pathways underlying complex human disorders are generally 169 consistent across populations, genetic heterogeneity has been observed. For example, 170 rs4246905, a variant in the TNFSF15-TNFSF8 locus, has a much larger protective effect for 171 Crohn's disease in EAS than EUR (95% confidence interval of odds ratio: 0.52-0.64 vs 0.85-172 0.89) 26 . For causal variants, heterogeneity of genetic effect across populations could arise from 173 clinical heterogeneity, differences in pathophysiology, exposures to different environmental 174 factors (GxE interaction), or interaction with other genetic factors (GxG interaction) that act non-175 additively with risk alleles. This large EAS sample allowed us, for the first time, to explore the 176 heterogeneity of genetic effects influencing liability to schizophrenia across two major world 177 populations. 178
Using LDSC 21 , we found the SNP-heritability of schizophrenia is very similar in EAS 179 (0.23±0.03) and EUR (0.24±0.02) (Methods and Extended Data Fig. 2a ). We also found that the 180 common-variant genetic correlation for schizophrenia between EAS and EUR was 181 indistinguishable from 1 (r g =0.98±0.03) (using POPCORN 27 , a method designed for cross-182 ancestry comparisons). This finding indicates that the common variant genetic architecture of 183 schizophrenia is basically identical across EAS and EUR. 184
Genetic correlations between schizophrenia and 11 other psychiatric disorders and 185 behavior traits also showed no significant differences when estimated within EUR and across 186 EAS-EUR (Extended Data Fig.2b ). In agreement with recent reports 28-31 , we observed 187 significant positive genetic correlations for schizophrenia with bipolar disorder, major depressive 188 disorder, anorexia nervosa, neuroticism, autism spectrum disorder, and educational attainment. 189
We observed significant negative correlations with general intelligence, fluid intelligence score, 190 prospective memory, and subjective well-being. 191
We used partitioned LDSC 21 to look for heritability enrichment in diverse functional 192 genomic annotations defined and used in previous publications 32, 33 We identified gene-sets that are enriched for schizophrenia genetic associations using 198 MAGMA 35 and gene-set definitions from a recent schizophrenia exome sequencing study 36 199 (Methods). Despite large differences in sample size and genetic background, the gene-sets 200 implicated in EAS and EUR samples were highly consistent: we observed no significant 201 differences between gene-set ranks using the EAS samples from the ranks using EUR samples 202 (P = 0.72, Wilcoxon test). In addition, 9 of the top 10 gene-sets identified using the EAS 203 samples are also among the top 10 gene-sets identified using EUR samples (Extended Data 204
Figure 3). 205
A study of EUR individuals suggested that common schizophrenia alleles are under 206 strong background selection 3 . We performed two analyses and found that the natural selection 207 signatures, including positive and background selections, are consistent in schizophrenia-208 associated loci across EAS and EUR populations. First, we compared the signatures in the top 209 100 associated loci in EAS to those in EUR. Among the selection signatures we calculated 210 (Methods), none showed a significant difference across populations (Extended Data Figure 4a , 211 P > 0.05 for all panels, two-sided t test). We next asked whether the population differentiation 212 drives schizophrenia variants to have different effect in different populations. Using 295 213 autosomal variants that are genome-wide significant in EAS, EUR or EAS-EUR combined 214 samples, we did not observe a correlation (R 2 =0.003, Extended Data Figure 4b ) between the 215 population differentiation (measured by F st ) and the heterogeneity of effect size (measured by 216 log 10 P-value from the heterogeneity test across EAS and EUR). 217
We compared the effect size estimates for schizophrenia associations in EAS versus 218 those in EUR. A precise comparison requires disease-causal variants and equivalent case and 219 control ascertainment schemes to avoid heterogeneity driven by differences in LD and 220 heterogeneity due to differences in cases and in controls. As we do not know the causal alleles 221 at the associated loci, we used the most significantly associated variants in EAS that are in LD 222 (R 2 >0.8) with the most significantly associated variants in EUR at each locus as an 223 approximation. We also restricted the comparison to variants that have P<10 -10 in EUR and 224 MAF > 10% in EAS as the estimates of the effect sizes for relatively common alleles that 225 substantially surpass genome-wide significance are least subject to inflationary bias in the 226 discovery set. None of the 21 associations that met these criteria showed significant differences 227 in the direction of effect ( Fig. 2a ) and moreover, the magnitude of the effect size was consistent 228 across the two populations with a modest bias from the winner's curse in the discovery (EUR) 229 samples (slope=0.67±0.09). 230 231
Schizophrenia genetic associations from the meta-analysis of EAS and EUR 232
As the genetic effects observed in EAS are largely consistent with those observed in EUR, we 233 performed a meta-analysis including the EUR and EAS samples (Stages 1 and 2) using a fixed-234 effect model with inverse-variance weighting 37 . The EUR samples in this analysis (56,418 cases 235 and 78,818 controls) included all samples of EUR ancestry from the previous publication 2 with 236 the exclusion of three samples of EAS ancestry and the deCODE samples (1,513 cases and 237 66,236 controls) which only had summary statistics for selected variants. The three EAS 238 samples (IMH-1, HNK-1 and JPN-1) excluded from EUR samples were included in our EAS 239 Stage 1. 240
We identified 208 independent (both in EAS and EUR) variants associated with 241 schizophrenia across 176 genetic loci ( Fig. 2b and Supplementary Tables 3 and 4) reported in the previous EUR study 2 , 89 remained significant in this study ( Supplementary Table  244 5). As suggested by Pardiñas et al. 3 , this reflects an expected over-estimation of the effect sizes 245 due to the winner's curse in the previous study, but does not mean the 19 loci not significant in 246 this study were false-positives in the previous study. In addition, deCODE samples were not 247 included in this analysis. 248 249
Population diversity improves fine-mapping 250
Due to LD, disease-associated loci from genome-wide association studies usually implicate 251 genomic regions containing many associated variants. A number of approaches allow for the 252 associated variants to be refined to a smaller set of the most plausible (or credible) candidate 253 causal variants [38] [39] [40] [41] . Loci implicated in psychiatric disorders usually have small effect sizes and 254 as a result, have generally poor performance using such approaches 2,3 . 255 Diversity in genetic background across populations can be used to improve fine-mapping 256 resolution 42 . Here we demonstrate that resolution can be improved by exploiting differences in 257 the patterns of LD between causal (directly associated) and LD (indirectly) associated variants. 258
Based on the premise that genetic effects are highly consistent across populations, the causal 259 variants will have consistent effects across populations whereas non-causal variants can have 260 inconsistent effects due to population-specific LD patterns. We therefore expect causal variants 261 to have greater statistical significance and less heterogeneity in trans-ancestry meta-analysis 262 compared to other alleles that are indirectly associated via LD (Extended Data Figure 5 ). Using 263 a new algorithm based on this presumption (Methods), we fine-mapped 133 schizophrenia 264 associations that reached genome-wide significance in the EUR and EAS (Stage 1) combined 265 meta-analysis (Supplementary Table 6 ). Stage 2 EAS samples were excluded because not all 266 had full genome coverage, which confounds the fine-mapping outcome (Methods). 267
Results from this EAS-EUR trans-ancestry approach improved upon those using only 268 EUR, with 93 loci mapped to a smaller number of candidate causal variants. For example, a 269 locus on chromosome 1 (238.8-239.4 Mb) which initially contained 7 potentially causal variants 270 based on a published fine-mapping method 38 and EUR samples was resolved to a single 271 variant, rs11587347, with 97.6% probability (Fig. 3a ). This variant showed strong association in 272 both populations, while the other 6 variants are equally associated in EUR but not in EAS ( Fig.  273 3b, c). Over all associations, the median size of the 95% credible set, defined as the minimum 274 list of variants that were >95% likely to contain the causal variant, dropped from 57 to 34; and 275 the number of associations mapped to ≤ 5 variants increased from 8 to 15 (Fig. 3d ). The number 276 of associations mapped to a single variant with greater than 50% probability increased from 16 277 to 20, and median size of the genomic regions the associations mapped decreased from 277 Kb 278 to 111 Kb. 279
Two schizophrenia associations were fine-mapped to coding variants including 280 SLC39A8 (A391T) with 44.8% probability, and WSCD2 (T226I) with 14.8% probability. The 281 SLC39A8 A391T variant causes deficiency in manganese homeostasis 43 and glycosylation 44 , 282 and is associated with Crohn's disease 45 , human gut microbiome composition 45 , hypertension 46 283 and intelligence 47 . In addition, using a similar strategy as in Huang et al. 38 , we found a 284 schizophrenia association (mapped to rs1700006 with 16.1% causal probability) implicating a 285 conserved transcription factor binding site (MEF2), which is 14 kb downstream of the nicotinic 286 receptor subunits CHRNA3 and CHRNB4. Finally, we searched for but did not find any 287 associations that implicate constrained nucleotides near exon splicing junctions 48 . 288 289
Transferability of genetics across populations 290
We compared the variance explained across EAS and EUR for genome-wide significant loci, 291 approximated as (ref 49), which explain >0.05% of the variance in 292 either ancestry (Extended Data Fig. 6 ). While these variants most often have the same effect 293 across populations, their allele frequencies can differ. Variance explained, combining the effect 294 size (OR) and prevalence of the risk allele ( ), can be regarded as an approximate measure of 295 the importance of a causal variant in a population. We found that most of the difference in 296 variance explained is driven by allele frequency differences. One of the implications of this 297 observation, as suggested in recent studies 20,50,51 , is that even if the risk alleles and effect sizes 298 are primarily shared across populations, the disease predictive power of individual alleles, and 299 of composite measures of those risk alleles such as PRS, may not be equivalent across 300
populations. 301
Here we evaluate this empirically. We assessed how much variation in schizophrenia 302 risk can be explained in EAS using both EAS Stage 1 and EUR training data. Using a standard 303 clumping approach, we first computed PRS using a leave-one-out meta-analysis approach with 304 EAS summary statistics (Methods), which explained ~3% of schizophrenia risk using genome-305 wide variants on the liability scale (R 2 = 0.029 at P=0.5). In contrast, when EUR summary 306 9 er b statistics were used to calculate PRS in the EAS samples, a maximum of only ~2% of 307 schizophrenia risk was explained (R 2 = 0.022 at P=0.1) despite a greater than 3-fold larger EUR 308 effective sample size ( Fig. 4 and Extended Data Fig. 7 ). The variance explained across various 309 P-value thresholds provides a proxy for the signal-to-noise ratio, which differs by training 310 population--relative to the EUR training data, variants from the EAS training data with more 311 permissive P-values improve the EAS prediction accuracy. These results indicate that larger 312 EAS studies will be needed to explain similar case/control variance as currently explained in 313 EUR individuals. Further, although individual loci typically have the same direction and similar 314 magnitude across populations, aggregating variants that differentially tag causal loci across 315 populations for genetic risk prediction results in considerable variability in prediction accuracy. 316
317

DISCUSSION 318
To date, most large-scale psychiatric genetics studies have been based on samples of primarily 319 EUR ancestry 6 . To increase global coverage, we compiled the largest non-European psychiatric 320 genetics cohort to date, and leveraged its size and diversity to provide new insights into the 321 genetic architecture of schizophrenia. This study included all available major genotyped 322 schizophrenia samples of East Asia ancestry, and presented analyses that had never been 323 performed with sufficient power in psychiatric genetics. 324
When a single population is used to identify the disease-associated loci, the discovery is 325 skewed towards disease-associated variants that have greater allele frequency in that 326 population (Extended Data Figure 8 ). When multiple populations are used, disease-associated 327 variants are equally represented across the allele frequency spectrum in these populations 328 (Extended Data Figure 8 ). This demonstrates that including global samples improves power to 329 find disease associations for which the power varies across populations. In this study, for 330 example, more EUR than EAS samples would be required to detect around half of the new loci, 331 as the MAF is higher in EAS than in EUR in these loci. 332
For traits like body mass index and autoimmune diseases, we observed heterogeneity 333 across populations in genetic effects 26,52 , which may point to interactions between genetic 334 associations and environment factors and/or other genetic loci. In contrast, for schizophrenia, 335
we did not find significant heterogeneity across EAS and EUR ancestries. Analyses in genetic 336 heritability, genetic correlation, gene-set enrichment and natural selection signatures all 337 converge to the same conclusion that the schizophrenia biology is substantially shared across 338 EAS and EUR, and likely, across other major world populations. This remarkable genetic 339 correlation (r g =0.98) across populations suggests, for the first time, that schizophrenia genetic 340 factors operate in an obedient fashion between ethnic and cultural backgrounds, and 341 schizophrenia across the world share the same genetic causes. Given that the mainstay 342 epidemiological factors (migration, urbanity and substance misuse) differ across populations, 343 this finding also suggests any specific genetic liability to schizophrenia acting via these routes is 344 minimal. 345
We note that a direct comparison of the effect sizes estimated in EAS with those 346 estimated in EUR has reduced accuracy as we do not know the exact schizophrenia causal 347 variants. This is further complicated by inflation in effect size estimates due to the winner's 348 curse, which are of different magnitudes due to the sample size. Increasing the sample size, 349 especially in those of non-European ancestries, will reduce the bias and enable a better 350 isolation of causal variants, leading to a more precise comparison of the genetic effect size 351 across populations. 352
The major histocompatibility complex (MHC) hosts the strongest schizophrenia 353 association in EUR 53 . In this study, we did not find a significant schizophrenia association in 354 MHC in EAS. An earlier EUR study 54 mapped the MHC associations to a set of variants (in LD) 355 at both distal ends of the extended MHC (lead variant: rs13194504) and the complement 356 component 4 (C4). Consistent with several studies of the Chinese ancestries 7,8,55,56 , none of 357 these associations was significant in EAS in this study. We attribute this partially to low 358 frequencies: rs13194504 has MAF < 1% in EAS comparing with 9% in EUR, and the C4-BS 359 allele is extremely uncommon in samples from China and Korea 57,58 . Another reason may be the 360 EUR-specific LD. In EUR, multiple protective alleles that contribute to the MHC associations are 361 all on the same haplotype across about 6 Mb, due to an extremely long and EUR-specific 362 haplotype that generates LD patterns at 5-Mb scale. This is also the reason that that association 363 signals span so many Mb of genome, and the aggregate association signal (at variants that are 364 in partial LD to multiple signals) is stronger than the signals at the individual associations. 365
Two recent studies using individuals of Chinese ancestries 7,8 reported variants in MHC 366 significantly associated with schizophrenia (rs115070292 and rs111782145 respectively, with 367 very weak LD with each other: R 2 =0.07), which are different and not in LD with the EUR MHC 368 associations. rs115070292, from Yu et al. 7 , is more frequent in EAS (12%) than in EUR (2%) 369 with P = 10 -9 using 4,384 cases and 5,770 controls of Chinese ancestry. This variant was not 370 significantly associated in our study (P = 0.44) even though some samples of the Chinese 371 studies were included in the current study (BJM-1, 1,312 cases and 1,987 controls). OR 372 estimated from these shared samples marginally differs from that estimated using all EAS 373 samples (P=0.018), and this association showed marginally significant heterogeneity across all 374 EAS samples (P=0.039). Similarly, we did not replicate the association at rs111782145 from Li 375 et al. 8 (P = 0.47) despite of the sample overlap (2,555 cases and 3,952 controls). Further 376 investigation with more samples is needed to delineate MHC associations in EAS and Chinese. 377
Genetic associations usually implicate a large genomic region and thus it can be 378 challenging to map their molecular functions. We designed a novel algorithm to leverage the 379 population diversity to fine-map schizophrenia associations to precise sets of variants. Using 380 this algorithm we reduced the number of candidate variants associated with schizophrenia and 381 facilitated the functional interpretation of these associations. Our algorithm assumed that there 382 is a single causal variant in a genetic locus associated with schizophrenia. Previous fine-383 mapping studies 38,59 have confirmed that this assumption is valid for most genetic loci 384 associated with complex disorders. 385
Finally, this large-scale EAS sample allowed us to empirically evaluate the congruence 386 of the genetic basis of schizophrenia between EAS and EUR. In spite of a cross-population 387 genetic correlation indistinguishable from 1, we found that polygenic risk models trained in one 388 population have reduced performance in the other population due to different allele frequency 389 distributions and LD structures. This highlights the importance of including all major ancestral 390 groups in genomic studies both as a strategy to improve power to find disease associations and 391 to ensure the findings have maximum relevance for all populations. 392 Author information 592
The study protocols were approved by the institutional review board at each center involved with 593 recruitment. Informed consent and permission to share the data were obtained from all subjects, 594
in compliance with the guidelines specified by the recruiting centre's institutional review board. 595
Samples that were recruited in mainland China were processed and analyzed in a 
Overview of samples 640
The following samples were used in this study: 641 EAS samples, full-genome: genome-wide genotype data was obtained from 16 EAS 642 samples from Singapore, Japan, Indonesia, Korea, Hong Kong, Taiwan, and mainland China 643 (Extended Data Table 1 ). Two of these samples (TAI-1 and TAI-2) had parents off-spring trios, 644 and were processed as case/pseudo-controls. DSM-IV was used for diagnosing all 645 schizophrenia cases in these samples except for the tros (TAI-1 and TAI-2), for which DIGS was were included in this study except for the deCODE samples (1,513 cases and 66,236 controls). 662
We also like to note that three samples of EAS ancestry reported in this publication were not 663 included in the EUR samples in our analysis but were included in the EAS samples (IMH-1, 664
HNK-1 and JPN-1). The same procedures used in processing EAS samples were applied to the 665 EUR samples. 666 667
Quality control 668
Quality control procedures were carried out as part of the RICOPILI pipeline 669 (https://sites.google.com/a/broadinstitute.org/ricopili/home) with the following steps and 670 parameters: 1) Excluding variants with call rate below 95%; 2) Excluding subjects with call rate 671 below 98%; 3) Excluding monomorphic variants; 4) Excluding subjects with inbred coefficient 672
Eight PCs that are associated with case/control status with P < 0.2 were used as 705 covariates for association analysis in each sample (PCs 1, 4, 5, 6, 8, 9, 15, and 19). QQ plots 706 (Extended Data Figure 1) showed that the population structure has been well controlled. 707 708
Association analysis and meta-analysis 709
Association analysis was carried out for each sample using PLINK 64 and genotype dosage from 710 imputation. Only variants having imputation INFO ≥ 0.6 and MAF ≥ 1% were included in the 711 analysis. We performed logistic regression with PCs identified in the prior subsection as 712 covariates to control for population stratification within each study. Fixed-effect meta-analysis 66 , 713 weighted by inverse-variance, was then used to combine the association results across 714 samples. Meta-analysis for European samples were conducted in the same matter. In order to 715 find independent schizophrenia associations in both EUR and EAS populations (Supplementary  716   Table 4 ), we performed LD clumping twice using the 1000 Genomes Project Phase 3 EUR and 717 EAS reference panels respectively (with default parameters in RICOPILI). 718
719 Chromosome X analysis 720 Chromosome X genotypes were processed separately from autosomal variants. Quality control 721 was conducted separately for males and females, using similar quality control parameters as 722 above. Cases and pseudo-controls were built out of the trios. Phasing and imputation were then 723 performed on males and females separately for each sample, followed by logistic regression 724 with the same PCs, and meta-analysis combining samples (same parameters as the autosomal 725 analyses). Results were generated for EAS Stage 1 samples and EUR-EAS combined samples 726 (excluding BIX1, BIX2 and BIX3). EAS Stage 2, BIX1, BIX2 and BIX3 samples do not have 727 chromosome X data and were therefore not analyzed. 728
729
Genetic correlation and heritability 730
Schizophrenia heritabilities in the observed scale for samples of EUR and EAS ancestry were 731 estimated from their summary statistics using the LDSC 21 . We converted the heritabilities in the 732 observed scale to liability scale assuming the schizophrenia population prevalence at 1%. The 733 LD scores were pre-computed from the 1000 Genomes Project Phase 3 reference panel in EUR 734 and EAS respectively (https://github.com/bulik/ldsc). Only autosomal variants having MAF 735 greater than 5% in their respective population were included in the analysis, and variants in the 736 MHC region were not included due to the long range LD. 737
We computed the genetic correlations between schizophrenia and other traits within 738 EUR and across EUR and EAS. EUR and EAS (Stage 1 only) summary statistics for autosomal 739 variants from this study were used as schizophrenia genetic association inputs for their 740 respective populations. Traits tested included schizophrenia 2 , bipolar 67 , major depression 68 , 741 anorexia nervosa 69 , neuroticism 70 , autism spectrum disorder (PGC 2015 release), attention 742 deficit hyperactivity disorder (with samples of non-European ancestry removed, available at 743 http://www.med.unc.edu/pgc) 71 , education attainment 72 , general intelligence 73 , fluid intelligence 744 score and prospective memory result (using individuals from UK Biobank), and subjective well 745 being (SWB) 70 . Only variants having MAF greater than 5% were available and included. 746
Variants in the MHC region were excluded from the analysis. Genetic correlations within EUR 747
were computed using LDSC with LD scores pre-computed on the 1000 Genomes Project Phase 748 3 reference panel (503 EUR subjects). Genetic correlations across EUR and EAS were 749 computed using POPCORN 27 . POPCORN uses a Bayesian approach which assumes that 750 genotypes are drawn separately from each population and effect sizes follow the infinitesimal 751 model. The inflation of z scores could then be modelled and a weighted likelihood function 752 which was maximized to find heritability and genetic correlation. Genetic correlations in 753 POPCORN were computed in the "genetic effect" mode, which estimates the correlation based 754 on the LD covariance scores and effect sizes from summary statistics. 755 756
Partitioned heritability 757
Partitioned LDSC 32 was conducted to look for heritability enrichment in diverse annotations 758 using EAS (Stage 1) and EUR autosomal variants (summary statistics) respectively. LD scores 759 for each annotation were computed using a combination of PLINK 64 and LDSC 21 using the 1000 760
Genomes Project EAS and EUR subjects respectively. We used baseline annotations 32 
Gene-set analysis 768
We performed gene and gene-set based tests using MAGMA 35 . Genome-wide summary 769 statistics for autosomal variants from EAS, EUR and EAS+EUR meta-analyses were used in 770 this analysis. Variant-to-gene annotation was performed using RefSeq NCBI37.3 with a window 771 of 5 Kb upstream and 1.5 Kb downstream. LD was taken from 1000 Genomes Project EAS, 772 EUR and EUR-EAS panels respectively. The gene-based P-values were computed using F-test 773 and multivariate linear model, and competitive tests were used for gene-set analysis. Seventy 774 gene-sets were selected and tested in this study ( Supplementary Table 7 ) including those from 775 the Molecular Signatures Database databases 75 , related to psychiatric diseases 36,76,77 and from 776 'gwaspipeline' (https://github.com/freeseek/gwaspipeline/blob/master/makegenes.sh). Gene-777 sets were ranked for EUR, EAS and EAS+EUR analyses respectively. The top ranking gene-778 sets were compared across analyses to identify common schizophrenia pathways. Additionally, 779
Wilcoxon sign rank tests was conducted to compare the ranking of gene-sets between the EUR 780 and EAS datasets. 781 782
Natural selection analysis 783
We used the CHB and CEU panels from the 1000 Genomes Project Phase 3 to investigate the 784 natural selection signatures in schizophrenia-associated loci for EAS and EUR populations 785 respectively. We used the following selection signatures, with their sensitivity to timeframes 786 For a disease-associated genetic locus, fine-mapping defines a "credible set" of variants that 805 contains the causal variant with certain probability (e.g., 99% or 95%). The Bayesian fine-806 mapping approaches 2,38,85,86 have been widely used for studies of a single ancestry. Here, we 807 extended a Bayesian fine-mapping approach 85 (Defining credible sets, Methods) to studies of 808 more than one ancestry. 809
Assume represents the data including the genotype matrix for all the variants 810 and disease status for individuals, and represents a collection of model parameters. We 811 define the model, denoted by , as the causal status for the variants in locus:
, in 812 which is the causal status for variant .
if the variant is causal, and if it is not. 813
We assume that there is one and only one genuine signal for each locus, and the causal variant 814 is the same across all ancestries; therefore, one and only one of the variants is causal: 815
. (1) 824 in which is the sample size. We denote as the test statistic for variant , which 825 can be calculated from the P-value from the meta-analysis combining EAS and EUR samples. (2) 828 is the prior probability that variant is causal. We have shown that schizophrenia 829 causal variants have consistent genetic effect across populations. Therefore we model the prior 830 probability as a function of the heterogeneity measured in : 831 .
(3) 832
Using equations 2 and 3, in equation 1 can be calculated as 833 27 nt ia r . 834
We only use Stage 1 samples in fine-mapping so the variants have the same sample 835 size (assuming all variants have good imputation quality). Therefore, , and 836 can be regarded as constants, 837
. 838
The normalized causal probability for variant is then 839 , 840 and the 95% credit set of variants is defined as the smallest set of variants, , such that 841 . 842
843
Polygenic risk score analysis 844
We constructed PRS using a pruning and thresholding approach in a study set of EAS 845 individuals with training summary statistics from either EUR or EAS individuals. In the former 846 case, we used summary statistics from all EUR individuals in this study; in the latter case, we 847 used a leave-one-out meta-analysis approach across the 13 Stage 1 samples to build PRS. 848
For the EUR training data, we extracted EUR individuals (FIN, GBR, CEU, IBS, TSI) 849 from 1000 Genomes Project 63 Phase 3 as an LD reference panel to greedily clump variants. For 850 the EAS LD reference panel, we created two panels: 1) an analogous EAS panel (CDX, CHB, 851 CHS, JPT, KHV) from 1000 Genome Project 63 Phase 3 ( Fig. 4 and Extended Data Fig. c and d) , 852
and 2) an LD panel from best guess genotypes from each cohort in the study (Extended Data 853 Fig. a,b ,e,f). For both EAS and EUR prediction sets, we filtered to variants with a MAF greater 854 than 1% in each respective populations, and removed indels and strand ambiguous variants. 855
We subset each list of variants to those in the summary statistics with an imputation INFO > 0.9. 856
We then selected approximately independent loci at varying P-value thresholds or top-ranking n 857 variants using an LD threshold of R 2 ≤ 0.1 in a window of 500 kilobase pairs in PLINK 64 with the 858 --clump flag. We treated the MHC with additional caution to minimize overfitting in this region, 859 selecting only the most significant variant from the HLA region. To profile variants, we multiplied 860 the log odds ratio for selected variants by genotypes and summed these values across the 861 genome in PLINK 64 using the --score flag for each of the 13 EAS Stage 1 samples. We 862 assessed case/control variance explained by computing Nagelkerke's and a liability-scale 863 28 or ), 
32
Different MAF is defined as Fst>0.01, and different OR is defined as heterogeneity test P-value < 0.05 33 after bonferroni correction. Nearest genes to the associations were used as labels for associations when 34 the text space is available, with the exception that the MHC locus was labeled as "MHC". 
